相关实验视频
Updated: Jul 17, 2026
06:17
Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
25.0K
蛋白质化合物巨细胞迁移抑制因子用于诊断绝经后骨质疏松症
Chendi Wang1,2, Fankai Huang1,2, Hehuan Lai1,2
1Department of Orthopedics, 5th Affiliated Hospital, Lishui Municipal Central Hospital, Wenzhou Medical College, Lishui, China.
Frontiers in chemistry
|February 23, 2026
概括
巨细胞迁移抑制因子 (MIF) 显示出作为绝经后骨质疏松症 (PMOP) 的早期诊断生物标志物的潜力. 在PMOP患者中血MIF水平升高表明骨代谢异常和风险.
科学领域:
- 生物化学 生物化学
- 内分泌学 在内分泌学.
- 骨生物学 骨生物学 骨生物学
背景情况:
- 绝经后骨质疏松症 (PMOP) 是一种重要的骨疾病,缺乏早期诊断生化标志物.
- 巨细胞迁移抑制因子 (MIF) 通过NF-κB通路参与骨重塑和炎症,但其在PMOP诊断中的作用尚不清楚.
研究的目的:
- 为了研究PMOP患者的血MIF表达模式.
- 评估MIF作为PMOP的潜在早期诊断生物标志物.
主要方法:
- 在PMOP患者和健康对照中测量了血MIF水平.
- 在MIF水平,骨矿物密度 (BMD) 和骨周转标记物 (β-CTX,PINP) 之间进行了相关性分析.
- 多变量分析评估了MIF作为PMOP的独立风险因素.
主要成果:
- 血MIF水平在PMOP患者 (1.72 ng/mL) 与对照组 (0.58 ng/mL) 相比显著更高.
- MIF水平与大腿部和腰椎BMD负相关.
- MIF与骨再吸收标记β-CTX和形成标记PINP正相关,表明骨稳定性受损.
结论:
- 血MIF升高与PMOP相关,反映了异常的骨代谢.
- MIF是一种独立的风险因素,也是PMOP早期诊断的有前途的生物标志物.
相关概念视频
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...